Laboratory diagnosis of human visceral leishmaniasis

Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne systemic disease, with a worldwide distribution causing high morbidity and mortality in the developing world. VL patients may be asymptomatic or they may present symptoms and findings of a systemic infection. T...

Full description

Bibliographic Details
Main Authors: Hercules Sakkas, Constantina Gartzonika, Stamatina Levidiotou
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Vector Borne Diseases
Subjects:
Online Access:http://www.mrcindia.orgjournal/article.asp?issn=0972-9062;year=2016;volume=53;issue=1;spage=8;epage=16;aulast=Sakkas
id doaj-71c88348dd784df390640a50f895e89d
record_format Article
spelling doaj-71c88348dd784df390640a50f895e89d2020-11-25T01:18:23ZengWolters Kluwer Medknow PublicationsJournal of Vector Borne Diseases0972-90622016-01-01531816Laboratory diagnosis of human visceral leishmaniasisHercules SakkasConstantina GartzonikaStamatina LevidiotouVisceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne systemic disease, with a worldwide distribution causing high morbidity and mortality in the developing world. VL patients may be asymptomatic or they may present symptoms and findings of a systemic infection. The positive predictive value of clinical diagnosis in patients with typical symptoms is usually high, but more often, the signs and symptoms are inconclusive and mistaken with other co-endemic diseases. The fact that HIV co-infections often produce atypical presentations and the heterogeneity of Leishmania species, which is common in many endemic regions, also complicate the diagnosis. Despite that, some of the parasitological methods are still considered to be the reference standard for VL diagnosis due to their specificity. The development of serological and molecular tests has further enhanced the diagnostic approach of VL. Recombinant antigens have improved the performance of serodiagnostic tests, with DAT and the rK39 antigen based immunochromatographic test being the most appropriate methods for the serological diagnosis of VL. Molecular techniques, despite the fact that their implementation is often difficult and infeasible, have become increasingly relevant due to remarkable sensitivity and specificity, and to the variability of tested samples. Quantitative polymerase chain reaction (qPCR) has been shown to be superior than conventional PCR for the differentiation between active VL and asymptomatic infections, such as for the detection of VL-HIV coinfection. This review summarizes the available methods with their applications in the diagnosis of VL, and focuses on the recent developments in VL diagnostics.http://www.mrcindia.orgjournal/article.asp?issn=0972-9062;year=2016;volume=53;issue=1;spage=8;epage=16;aulast=SakkasDiagnosis; HIV coinfection; Phlebotomus; visceral leishmaniasis
collection DOAJ
language English
format Article
sources DOAJ
author Hercules Sakkas
Constantina Gartzonika
Stamatina Levidiotou
spellingShingle Hercules Sakkas
Constantina Gartzonika
Stamatina Levidiotou
Laboratory diagnosis of human visceral leishmaniasis
Journal of Vector Borne Diseases
Diagnosis; HIV coinfection; Phlebotomus; visceral leishmaniasis
author_facet Hercules Sakkas
Constantina Gartzonika
Stamatina Levidiotou
author_sort Hercules Sakkas
title Laboratory diagnosis of human visceral leishmaniasis
title_short Laboratory diagnosis of human visceral leishmaniasis
title_full Laboratory diagnosis of human visceral leishmaniasis
title_fullStr Laboratory diagnosis of human visceral leishmaniasis
title_full_unstemmed Laboratory diagnosis of human visceral leishmaniasis
title_sort laboratory diagnosis of human visceral leishmaniasis
publisher Wolters Kluwer Medknow Publications
series Journal of Vector Borne Diseases
issn 0972-9062
publishDate 2016-01-01
description Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne systemic disease, with a worldwide distribution causing high morbidity and mortality in the developing world. VL patients may be asymptomatic or they may present symptoms and findings of a systemic infection. The positive predictive value of clinical diagnosis in patients with typical symptoms is usually high, but more often, the signs and symptoms are inconclusive and mistaken with other co-endemic diseases. The fact that HIV co-infections often produce atypical presentations and the heterogeneity of Leishmania species, which is common in many endemic regions, also complicate the diagnosis. Despite that, some of the parasitological methods are still considered to be the reference standard for VL diagnosis due to their specificity. The development of serological and molecular tests has further enhanced the diagnostic approach of VL. Recombinant antigens have improved the performance of serodiagnostic tests, with DAT and the rK39 antigen based immunochromatographic test being the most appropriate methods for the serological diagnosis of VL. Molecular techniques, despite the fact that their implementation is often difficult and infeasible, have become increasingly relevant due to remarkable sensitivity and specificity, and to the variability of tested samples. Quantitative polymerase chain reaction (qPCR) has been shown to be superior than conventional PCR for the differentiation between active VL and asymptomatic infections, such as for the detection of VL-HIV coinfection. This review summarizes the available methods with their applications in the diagnosis of VL, and focuses on the recent developments in VL diagnostics.
topic Diagnosis; HIV coinfection; Phlebotomus; visceral leishmaniasis
url http://www.mrcindia.orgjournal/article.asp?issn=0972-9062;year=2016;volume=53;issue=1;spage=8;epage=16;aulast=Sakkas
work_keys_str_mv AT herculessakkas laboratorydiagnosisofhumanvisceralleishmaniasis
AT constantinagartzonika laboratorydiagnosisofhumanvisceralleishmaniasis
AT stamatinalevidiotou laboratorydiagnosisofhumanvisceralleishmaniasis
_version_ 1725142896409051136